NASHVILLE, Tenn. - Terence J. O’Brien, MB, BS, MD, FRACP, FRCPE, FAHMS, FAES presented the Fritz E. Dreifuss lecture during the Presidential Symposium at the 2022 Annual Meeting of the American Epilepsy Society (AES). Dr. O’Brien presentation was titled The ‘Dreamy State’: John Hughlings-Jackson’s Description of TLE.
Dr. O’Brien is Chair of Medicine (Neurology) and Head, Central Clinical School, Monash University and Program Director, Alfred Brain, and Deputy Director of Research, Alfred Health. He is a specialist in neurology and clinical pharmacology, with particular expertise in epilepsy and neurodegenerative diseases, pre-clinical and clinical trials, and in-vivo imaging in animal models and humans. He leads a large translational research team undertaking both basic studies and clinical studies focused on developing improved treatments for people with epilepsy and related brain diseases, including traumatic brain injury, dementias, and brain tumors. He has been involved as a Principle Investigator in >150 commercially sponsored and investigator-initiated clinical trials of new treatments for epilepsy, dementias, headache, movement disorders, and new PET radiotracers. He has published >650 peer-reviewed original papers in leading scientific and medical journals which have been cited >28,000 times (H-Index 85).
He has also held many major leadership roles in the Australian and International Epilepsy and Neurology professional societies, including Chair of the Australian Epilepsy Clinical Trials Network (AECTN), VIC/TAS State Branch Chair 2019, Australian Academy of Health and Medical Sciences, and Chair of the Translational Research Committee, American Epilepsy Society. He is the immediate past President of the Epilepsy Society of Australia (2018-21).